172 related articles for article (PubMed ID: 20008045)
1. Detection of a new extended-spectrum oxacillinase in Pseudomonas aeruginosa.
Fournier D; Hocquet D; Dehecq B; Cholley P; Plésiat P
J Antimicrob Chemother; 2010 Feb; 65(2):364-5. PubMed ID: 20008045
[No Abstract] [Full Text] [Related]
2. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
Wang C; Cai P; Chang D; Mi Z
J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065
[No Abstract] [Full Text] [Related]
3. Isolation of an extended spectrum beta-lactamase producing Pseudomonas aeruginosa from a patient in a Sydney hospital.
Bell SM; Pham JN; Gatus BJ; Poirel L; Nordmann P
Pathology; 2007 Feb; 39(1):189-90. PubMed ID: 17365844
[No Abstract] [Full Text] [Related]
4. Emergence of extended-spectrum-AmpC-expressing Escherichia coli isolates in Belgian hospitals.
Bogaerts P; Rodriguez-Villalobos H; Laurent C; Deplano A; Struelens MJ; Glupczynski Y
J Antimicrob Chemother; 2009 May; 63(5):1073-5. PubMed ID: 19240070
[No Abstract] [Full Text] [Related]
5. Detection of blaVIM-2 carbapenemase in Pseudomonas aeruginosa in Ireland.
Walsh F; Rogers TR
J Antimicrob Chemother; 2008 Jan; 61(1):219-20. PubMed ID: 18024489
[No Abstract] [Full Text] [Related]
6. Spread of the bla(IMP-13) gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111.
Fournier D; Jeannot K; Robert-Nicoud M; Muller E; Cholley P; van der Mee-Marquet N; Plésiat P
Int J Antimicrob Agents; 2012 Dec; 40(6):571-3. PubMed ID: 23089049
[No Abstract] [Full Text] [Related]
7. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey.
Yakupogullari Y; Poirel L; Bernabeu S; Kizirgil A; Nordmann P
J Antimicrob Chemother; 2008 Jan; 61(1):221-2. PubMed ID: 17981831
[No Abstract] [Full Text] [Related]
8. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina.
Pasteran F; Faccone D; Petroni A; Rapoport M; Galas M; Vázquez M; Procopio A
Antimicrob Agents Chemother; 2005 Jan; 49(1):474-5. PubMed ID: 15616342
[No Abstract] [Full Text] [Related]
9. Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa.
Zhao WH; Hu ZQ
Crit Rev Microbiol; 2010 Aug; 36(3):245-58. PubMed ID: 20482453
[TBL] [Abstract][Full Text] [Related]
10. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.
Yan JJ; Tsai SH; Chuang CL; Wu JJ
J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and characterization of metallo-beta-lactamases in clinical isolates of pseudomonas aeruginosa.
Luzzaro F; Endimiani A; Docquier JD; Mugnaioli C; Bonsignori M; Amicosante G; Rossolini GM; Toniolo A
Diagn Microbiol Infect Dis; 2004 Feb; 48(2):131-5. PubMed ID: 14972383
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country.
Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A
J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087
[TBL] [Abstract][Full Text] [Related]
14. [Resistance caused by hyperproduction of chromosomal beta-lactamase in Pseudomonas aeruginosa].
Tirado M; Hermida M; Reig R; Esteva C; Vidal R; Roy C
Enferm Infecc Microbiol Clin; 1989 Dec; 7(10):530-4. PubMed ID: 2518765
[TBL] [Abstract][Full Text] [Related]
15. VIM-5 metallo-beta-lactamase-producing Pseudomonas putida from Turkey.
Poirel L; Yakupoğullari Y; Kizirgil A; Dogukan M; Nordmann P
Int J Antimicrob Agents; 2009 Mar; 33(3):287. PubMed ID: 18805676
[No Abstract] [Full Text] [Related]
16. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey.
Bahar G; Mazzariol A; Koncan R; Mert A; Fontana R; Rossolini GM; Cornaglia G
J Antimicrob Chemother; 2004 Jul; 54(1):282-3. PubMed ID: 15190017
[No Abstract] [Full Text] [Related]
17. Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units.
Paez J; Levin AS; Fu L; Basso M; Fonseca GH; Dulley FL; Rossi F; Guimarães T; Costa SF
J Hosp Infect; 2011 Jan; 77(1):76-7. PubMed ID: 21030111
[No Abstract] [Full Text] [Related]
18. Isolation and characterization of an imported extremely-resistant Pseudomonas aeruginosa producing three different extended-spectrum β-lactamases and hyperproducing two multidrug-efflux pumps.
Ratkai C; Nagy E; Peixe L; Bertalan V; Hajdú E
J Infect; 2010 Dec; 61(6):511-2. PubMed ID: 20951729
[No Abstract] [Full Text] [Related]
19. Identification of bla(IMP-22) in Pseudomonas spp. in urban wastewater and nosocomial environments: biochemical characterization of a new IMP metallo-enzyme variant and its genetic location.
Pellegrini C; Mercuri PS; Celenza G; Galleni M; Segatore B; Sacchetti E; Volpe R; Amicosante G; Perilli M
J Antimicrob Chemother; 2009 May; 63(5):901-8. PubMed ID: 19270313
[TBL] [Abstract][Full Text] [Related]
20. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
